MiR-143-3p suppresses the progression of ovarian cancer

被引:13
|
作者
Shi, Haijuan [1 ]
Shen, Huimin [2 ]
Xu, Juan [3 ]
Zhao, Shanshan [2 ]
Yao, Shuzhong [2 ]
Jiang, Nan [2 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 2, Guangxi, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, 58 Zhongshan 2 Rd, Guangzhou 510080, Guangdong, Peoples R China
[3] Zhejiang Univ, Jinhua Hosp, Jinhua Municipal Cent Hosp, Jinhua 321000, Zhejiang, Peoples R China
来源
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 2018年 / 10卷 / 03期
关键词
MiR-143-3p; ovarian cancer; proliferation; migration; xenograft; TAK1; DOWN-REGULATION; MICRORNAS; TAK1; APOPTOSIS; ONCOMIRS; CELLS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) are a class of naturally occurring, small, non-coding RNAs that target protein-coding mRNAs at the post-transcriptional level and participate in various biological processes. Our previous studies suggested that miR-143-3p functions as a tumor suppressor and has a role in the progression of ovarian cancer, in part through the regulation of the tumor promoter. In this study, we found that the mRNA expression level of miR-143-3p was significantly decreased in ovarian cancer tissues, in comparison with normal ovarian tissues by high-throughput miRNA profiling and quantitative RT-PCR. Secondly, we indicated that the up-regulation of miR-143-3p in the ovarian cancer cell lines SKOV3, ES2, and OVCAR3 significantly reduced their proliferation, migration, and invasion. Furthermore, miR-143-3p inhibited the growth of ovarian tumors in vivo in a xenograft experiment. In addition, miR-143-3p down-regulated the expression of transforming growth factor (TGF)-ss-activated kinase 1 (TAK1) in human ovarian cancer cells. Therefore, our study indicates that miR-143-3p inhibited the proliferation, migration, and invasion of ovarian cancer cells in vitro, as well as ovarian tumorigenesis in vivo. This inhibitory effect may target TAK1, suggesting a potential application of the miR-143-3p-TAK1 pathway in the clinical diagnosis and treatment of ovarian cancer.
引用
收藏
页码:866 / 874
页数:9
相关论文
共 50 条
  • [1] miR-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells
    Li, Dengfeng
    Hu, Jiashu
    Song, Hongming
    Xu, Hui
    Wu, Chengyang
    Zhao, Bingkun
    Xie, Dan
    Wu, Tianqi
    Zhao, Junyong
    Fang, Lin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (05): : 2276 - 2285
  • [2] MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS
    Xie, Fei
    Li, Chuan
    Zhang, Xiaoyun
    Peng, Wei
    Wen, Tianfu
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 119
  • [3] Identification of miR-143-3p as a diagnostic biomarker in gastric cancer
    Ju, Yeongdon
    Choi, Go-Eun
    Lee, Moon Won
    Jeong, Myeongguk
    Kwon, Hyeokjin
    Kim, Dong Hyeok
    Kim, Jungho
    Jin, Hyunwoo
    Lee, Kyung Eun
    Hyun, Kyung-Yae
    Jang, Aelee
    BMC MEDICAL GENOMICS, 2023, 16 (01)
  • [4] Identification of miR-143-3p as a diagnostic biomarker in gastric cancer
    Yeongdon Ju
    Go-Eun Choi
    Moon Won Lee
    Myeongguk Jeong
    Hyeokjin Kwon
    Dong Hyeok Kim
    Jungho Kim
    Hyunwoo Jin
    Kyung Eun Lee
    Kyung-Yae Hyun
    Aelee Jang
    BMC Medical Genomics, 16
  • [5] Dexmedetomidine suppresses the progression of esophageal cancer via miR-143-3p/epidermal growth factor receptor pathway substrate 8 axis
    Zhang, Peisen
    He, Hefan
    Bai, Yuyan
    Liu, Weifeng
    Huang, Lirong
    ANTI-CANCER DRUGS, 2020, 31 (07) : 693 - 701
  • [6] Targeting of AKT1 by miR-143-3p Suppresses Epithelial-to-Mesenchymal Transition in Prostate Cancer
    Armstrong, Lee
    Willoughby, Colin E.
    Mckenna, Declan J.
    CELLS, 2023, 12 (18)
  • [7] LINC00460/miR-143-3p/Serpine1 in Promoting Gastric Cancer (GC) Progression
    Li, Wulong
    Yu, Haitao
    Wei, Dan
    Ouyang, Gen
    Li, Ying
    Tu, Qing
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2023, 13 (11) : 1082 - 1093
  • [8] Resveratrol promotes mitophagy via the MALAT1/miR-143-3p/RRM2 axis and suppresses cancer progression in hepatocellular carcinoma
    Feng, Chun-yan
    Cai, Cheng-song
    Shi, Xiao-qian
    Zhang, Zhi-juan
    Su, Dan
    Qiu, Yun-qing
    JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2025, 23 (01): : 79 - 92
  • [9] Resveratrol promotes mitophagy via the MALAT1/miR-143-3p/RRM2 axis and suppresses cancer progression in hepatocellular carcinoma
    Chunyan Feng
    Chengsong Cai
    Xiaoqian Shi
    Zhijuan Zhang
    Dan Su
    Yunqing Qiu
    Journal of Integrative Medicine, 2025, 23 (01) : 79 - 92
  • [10] The Role of miR-143-3p in Podocyte Damage in Preeclampsia
    Suvakov, Sonja
    Gojkovic, Tamara
    Garovic, Vesna D.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 262 - 262